Danny Godfrey | egt co-founder / director
Risk goes hand in hand with medical device design and development – intervening in the human body will always have the potential to go wrong. But what happens when device limitations could result in serious injury or even death?Join egt director, Danny Godfrey as he looks specifically at the design and development of in-vivo devices and how risks are identified, managed, and mitigated to minimize the risk of potentially catastrophic outcomes. Starting with a brief overview of the medical device development process, this webinar will address the importance of examining the full use cycle of your device and identifying risks early on in your project – including less obvious and sometimes unseen obstacles – whilst ensuring full traceability throughout.
You will learn:
- The key things to consider from the outset of any development programme
- How to identify the full spectrum of potential risks
- When in your programme this should happen
- The importance of device classification and mapping risks against standards
- How to mitigate risks to allow you to get on with your design
Contact loisdixon@egtechnology.co.uk to register your interest.
You can follow @egtechnology on Twitter.
